PAR / NSE / Biotechnology & Drugs
Par Drugs and Chemicals
1Y Price Trend
Key Information
Recommendations
Target High122.43
Target Low78.05
Target Mean0
Target Median0
Risk Metrics
StatusNot available
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Par Drugs & Chemicals Ltd is Rated Sell Markets Mojo
Par Drugs & Chemicals Ltd is Rated Hold Markets Mojo
Jocil Ltd Q4 FY26: Margin Recovery Drives Profitability Surge Despite Valuation Concerns MarketsMojo
Par Drugs & Chemicals Ltd is Rated Sell Markets Mojo
Par Drugs faces Rs 20.09 lakh tax demand due to filing error scanx.trade
Par Drugs & Chemicals Ltd Reports Sharp Decline in Quarterly Financial Performance Amid Negative Trend Shift Markets Mojo
Q4 Results Today LIVE Updates: JSW Steel, HAL, Muthoot Finance, IRFC, Voltas among 147 companies set to declare quarterly earnings for FY26 - Check full list and updates Dailyhunt
Par Drugs & Chemicals standalone net profit declines 48.48% in the March 2026 quarter Business Standard
© SharekeyX | Rusaka Technologies 2024-2026

